Name	Value
Compound	MLS-2384
Investigated event	Influence on tumor growth
Experiment type	Body weight
Concentration	50.00 mg/kg
Cell line	A2058 (xenograft)
Organism	Mus musculus
Animal model	BALB/c
STAT protein
Other

MLS-2384, a new 6-bromoindirubin derivative with dual JAK/Src kinase inhibitory activity, suppresses growth of diverse cancer cells. Cancer biology & therapy Lucy Liu, Nicolas Gaboriaud, Konstantina Vougogianopoulou, Yan Tian, Jun Wu, Wei Wen, Leandros Skaltsounis, Richard Jove, 15, 2, None, 2013-11-01, 10.4161/cbt.26721 DOI: 10.4161/cbt.26721 PUBMED: 24100507 PMCID: PMC3928133